Works matching IS 20499434 AND DT 2022 AND VI 16 AND IP 2

Results: 6

Next-generation sequencing as an advanced supplementary tool for the diagnosis of pathogens in lower respiratory tract infections: An observational trial in Xi'an, China.
Published in:
Biomedical Reports, 2022, v. 16, n. 2, p. 1, doi. 10.3892/br.2021.1497
By:
- JIE SHAO;
- HASSOUNA, AMIRA;
- YAQIN WANG;
- RUIRUI ZHANG;
- LIFANG ZHEN;
- RUIDAN LI;
- MINGLI CHEN;
- CHENGJIE LIU;
- XIANGYE WANG;
- MINGMING ZHANG;
- PENG WANG;
- SHENGHUA YUAN;
- JIE CHEN;
- JUN LU
Publication type:
Article
Nasopharyngeal and oropharyngeal rinses with neutral electrolyzed water prevents COVID-19 in front-line health professionals: A randomized, open-label, controlled trial in a general hospital in Mexico City.
Published in:
Biomedical Reports, 2022, v. 16, n. 2, p. 1, doi. 10.3892/br.2021.1494
By:
- GUTIÉRREZ-GARCÍA, RAFAEL;
- DE LA CERDA-ÁNGELES, JUAN C.;
- CABRERA-LICONA, ARIANA;
- DELGADO-ENCISO, IVAN;
- MERVITCH-SIGAL, NICOLAS;
- PAZ-MICHEL, BRENDA A.
Publication type:
Article
Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis.
Published in:
Biomedical Reports, 2022, v. 16, n. 2, p. 1, doi. 10.3892/br.2021.1495
By:
- ČIZMAREVIĆ, NADA STARČEVIĆ;
- ĆURKO-COFEK, BOŽENA;
- BARAC-LATAS, VESNA;
- PETERLIN, BORUT;
- RISTIĆ, SMILJANA
Publication type:
Article
Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19.
Published in:
Biomedical Reports, 2022, v. 16, n. 2, p. 1, doi. 10.3892/br.2021.1496
By:
- ABDELHAKAM, DINA A.;
- BADR, FATMA MOHAMMED;
- TEAMA, MOHAMMED ABD EL MONEM;
- ELMIHI, NOURAN M. BAHIG;
- EL-MOHAMDY, MARWA ADHAM
Publication type:
Article
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report.
Published in:
2022
By:
- CECCARELLI, MANUELA;
- MARINO, ANDREA;
- COSENTINO, FEDERICA;
- MOSCATT, VITTORIA;
- CELESIA, BENEDETTO MAURIZIO;
- GUSSIO, MARIA;
- BRUNO, ROBERTO;
- RULLO, EMMANUELE VENANZI;
- NUNNARI, GIUSEPPE;
- CACOPARDO, BRUNO SANTI
Publication type:
Case Study
The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection.
Published in:
Biomedical Reports, 2022, v. 16, n. 2, p. 1, doi. 10.3892/br.2021.1492
By:
- KOSUKE MATSUMOTO;
- HISAMITSU MIYAAKI;
- MASANORI FUKUSHIMA;
- RYU SASAKI;
- MASAFUMI HARAGUCHI;
- SATOSHI MIUMA;
- KAZUHIKO NAKAO
Publication type:
Article

Works matching IS 20499434 AND DT 2022 AND VI 16 AND IP 2

Next-generation sequencing as an advanced supplementary tool for the diagnosis of pathogens in lower respiratory tract infections: An observational trial in Xi'an, China.

Nasopharyngeal and oropharyngeal rinses with neutral electrolyzed water prevents COVID-19 in front-line health professionals: A randomized, open-label, controlled trial in a general hospital in Mexico City.

Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis.

Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19.

Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report.

The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection.